| Literature DB >> 31441733 |
Zhe Gong1,2, Kaishun Xia1,2, Ankai Xu1,2, Chao Yu1,2, Chenggui Wang1,2, Jian Zhu1,2, Xianpeng Huang1,2, QiXin Chen1,2, Fangcai Li1,2, Chengzhen Liang1,2.
Abstract
Spinal Cord Injury (SCI) causes irreversible functional loss of the affected population. The incidence of SCI keeps increasing, resulting in huge burden on the society. The pathogenesis of SCI involves neuron death and exotic reaction, which could impede neuron regeneration. In clinic, the limited regenerative capacity of endogenous cells after SCI is a major problem. Recent studies have demonstrated that a variety of stem cells such as induced Pluripotent Stem Cells (iPSCs), Embryonic Stem Cells (ESCs), Mesenchymal Stem Cells (MSCs) and Neural Progenitor Cells (NPCs) /Neural Stem Cells (NSCs) have therapeutic potential for SCI. However, the efficacy and safety of these stem cellbased therapy for SCI remain controversial. In this review, we introduce the pathogenesis of SCI, summarize the current status of the application of these stem cells in SCI repair, and discuss possible mechanisms responsible for functional recovery of SCI after stem cell transplantation. Finally, we highlight several areas for further exploitation of stem cells as a promising regenerative therapy of SCI. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Chondrogenic differentiation; adipogenic differentiation; alveolar epithelial cells; cardiomyocytes; endothelial cells; neurons; nucleus; pulposus-zzm321990like cells; schwann cells.
Year: 2020 PMID: 31441733 DOI: 10.2174/1574888X14666190823144424
Source DB: PubMed Journal: Curr Stem Cell Res Ther ISSN: 1574-888X Impact factor: 3.828